Skip to content

Comparing Dry Needling and IASTM for Alleviating Upper Back Myofascial Pain Syndrome

Effects of dry needling versus instrument assisted soft tissue mobilization (iastm) on upper back myofascial pain syndrome-A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087571
Enrollment
90
Registered
2025-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure

Interventions

Intervention1: IASTM DRY NEEDLING: IASTM is based on these principles and it is a technique that is a modified version of traditional soft tissue mobilization such as Gua Sha IASTM includes augmented

Sponsors

UPUMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with a diagnosis of upper back myofascial pain syndrome (UBMPS), confirmed by orthopedic professionals. 2 Age: Between 18 and 65 years. 3 Duration of pain: At least 4 weeks 4 Pain intensity: A score of 3 or higher on a numerical pain rating scale (NPRS) at baseline. 5 Consent: Willingness to participate in the study and provide informed consent for invasive techniques.

Exclusion criteria

Exclusion criteria: I. Other conditions: Patients with any other musculoskeletal or systemic conditions that could significantly affect the study outcomes. II. Previous treatments: Patients who have undergone any invasive treatments for UBMPS within the past 3 months, such as surgery, injections. III. Medication: Patients taking any medications that could interfere with pain perception or muscle function. IV. Cognitive impairment: Patients with cognitive impairment that would prevent them from understanding or participating in the study. V. Substance abuse: Patients with active substance abuse problems.

Design outcomes

Primary

MeasureTime frame
Global Pain ScaleTimepoint: baseline and 2 weeks

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactAsif Equebal

UTTAR PRADESH UNIVERSITY OF MEDICAL SCIENCES, SAIFAI, ETAWAH (U.P.)

chaudhry.ranjeet@rediffmail.com9760690454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026